Also trades as: PANACEABIO.BO (BSE) · $vol 0M
PANACEABIO.NS NSE
Panacea Biotec Limited
1W: -4.2%
1M: -8.2%
3M: -34.9%
YTD: -4.1%
1Y: -14.6%
3Y: +176.0%
5Y: +1.6%
₹354.00 ($3.68)
-5.05 (-1.41%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$173M
+163.4% ▲
5Y CAGR: -30.5%
Capital Expenditures
$541M
-7.5% ▼
5Y CAGR: +20.0%
Free Cash Flow
-$368M
+52.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$178M
-150.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $14.5B | $128M | -$12M | -$80M | -$54M |
| Depreciation & Amort. | $438M | $391M | $367M | $348M | $331M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $3.0B | -$3.4B | $97M | -$86M | $140M |
| Other Non-Cash Items | -$19.0B | -$1.4B | -$453M | -$456M | -$243M |
| Operating Cash Flow | -$1.1B | -$4.2B | -$1M | -$274M | $173M |
| — Investing Activities — | |||||
| Capital Expenditures | -$125M | -$409M | -$777M | -$503M | -$541M |
| Acquisitions (Net) | $18.2B | $395M | $0 | $0 | $0 |
| Investment Purchases | -$10.5B | -$8.7B | -$3.5B | -$2.2B | -$3.5B |
| Investment Sales | $5.2B | $12.9B | $4.2B | $3.2B | $3.5B |
| Other Investing | $53M | $116M | $151M | $101M | $20M |
| Investing Cash Flow | $12.8B | $4.3B | $102M | $650M | -$456M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$7.9B | -$148M | -$2M | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$3.9B | -$36M | -$26M | -$27M | $34M |
| Financing Cash Flow | -$11.8B | -$184M | -$28M | -$27M | $34M |
| Net Change in Cash | -$17M | -$105M | $73M | $350M | -$178M |
| Cash End of Period | $504M | $399M | $472M | $821M | $644M |
| Free Cash Flow | -$1.2B | -$4.6B | -$778M | -$777M | -$368M |